The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement control protein-CR2 chimeras

A.A. Johnson, A.M. Rosengard, K. Skjødt, J.M. Ahearn, R.G.Q. Leslie

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

OriginalsprogEngelsk
TidsskriftEuropean Journal of Immunology
Vol/bind29
Sider (fra-til)3837-3844
ISSN0014-2980
StatusUdgivet - 1999

Citationsformater